|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
August 17, 2006
Trial Results Published in Neurology Show Risk of Developing Multiple Sclerosis Significantly Reduced with Interferon Beta-1b Early Treatment
BETASERON: Trial Results Published in Neurology Show Risk of Developing Multiple Sclerosis Significantly Reduced with Interferon Beta-1b Early Treatment "Researchers have found that treatment of patients with interferon beta-1b after a first attack suggestive of MS cuts their risk of developing the disease in half over the next two years, according to results from the BENEFIT (BEtaferon(R)/BEtaseron(R) in Newly Emerging MS for Initial Treatment) clinical trial..... |